immunostimulatory
Showing 1 - 25 of 130
Healthy Volunteers Trial in Singapore (Gentamicin, Placebo)
Recruiting
- Healthy Volunteers
- Gentamicin
- Placebo
-
Singapore, SingaporeSingapore General Hospital
May 11, 2022
Renal Cell Carcinoma, Renal Cell Carcinoma Stage IV Trial in Philadelphia (Nivolumab, Ipilimumab, bland embolization)
Recruiting
- Renal Cell Carcinoma
- Renal Cell Carcinoma Stage IV
- Nivolumab
- +2 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Mar 14, 2022
Advanced Malignant Solid Tumor, Extracranial Solid Tumor, Metastatic Malignant Solid Tumor Trial in Palo Alto (Anti-OX40
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Anti-OX40 Antibody BMS 986178
- TLR9 Agonist SD-101
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
Jun 13, 2022
Immunotherapy Trial in Suwon (Part A) Healthy subjects, Part B) Advanced solid tumor)
Completed
- Immunotherapy
- Part A) Healthy subjects
- Part B) Advanced solid tumor
-
Suwon, Gyeong-gi Do, Korea, Republic ofAjou university hosiptal
Jul 2, 2021
Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Palo Alto (Ibrutinib, Radiation
Active, not recruiting
- Grade 1 Follicular Lymphoma
- +6 more
- Ibrutinib
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Jun 13, 2022
B-Cell Non-Hodgkin Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma Trial in Palo Alto (biological, other,
Active, not recruiting
- B-Cell Non-Hodgkin Lymphoma
- +7 more
- Anti-OX40 Antibody BMS 986178
- +3 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
May 3, 2022
HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Myxoid Liposarcoma Trial in Houston
Active, not recruiting
- HLA-A*0201 Positive Cells Present
- +3 more
- Aldesleukin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Infection, Enterocolitis, Necrotizing, Ventilator-associated Pneumonia Trial in United States (oropharyngeal mother's milk,
Active, not recruiting
- Infection
- +2 more
- oropharyngeal mother's milk
- oropharyngeal sterile water
-
Miami, Florida
- +4 more
Apr 8, 2022
Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)
Not yet recruiting
- Oral Squamous Cell Carcinoma
-
Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Apr 5, 2023
Colorectal Tumors Trial in Santa Monica, Washington, Bethesda (1018 ISS immunostimulatory oligonucleotide)
Terminated
- Colorectal Neoplasms
- 1018 ISS immunostimulatory oligonucleotide
-
Santa Monica, California
- +2 more
Apr 11, 2019
Anthrax Trial in United States (AV7909 Full Dose (0.5 mL), AV7909 Half Dose (0.25 mL))
Not yet recruiting
- Anthrax
- AV7909 Full Dose (0.5 mL)
- AV7909 Half Dose (0.25 mL)
-
Hickory, North Carolina
- +6 more
Aug 10, 2023
SARS-CoV2 Infection Trial in Sousse, Sahloul (Nigella, Placebo)
Completed
- SARS-CoV2 Infection
- Nigella
- Placebo
-
Sousse, Itinéraire Ceinture Cité Sahloul, Tunisia
- +1 more
Feb 18, 2022
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Stanford (biological, drug, radiation)
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +6 more
- Ipilimumab
- +2 more
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Nov 17, 2019
Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders
Completed
- HIV Infections
- +2 more
-
Baltimore, Maryland
- +1 more
Mar 17, 2023
SARS (Severe Acute Respiratory Syndrome) Trial in Sousse, Sahloul (Quercetin, Placebo)
Completed
- SARS (Severe Acute Respiratory Syndrome)
- Quercetin
- Placebo
-
Sousse, Itinéraire Ceinture Cité Sahloul, Tunisia
- +1 more
Jan 2, 2023
Hepatitis B Trial in United States (1018 ISS immunostimulatory oligonucleotide with HBV surface antigen, Hepatitis B Vaccine
Completed
- Hepatitis B
- 1018 ISS immunostimulatory oligonucleotide with HBV surface antigen
- Hepatitis B Vaccine (Recombinant)
-
Costa Mesa, California
- +3 more
Mar 18, 2019
Seasonal Allergic Rhinitis Trial in Baltimore (AIC (Amb a 1 Immunostimulatory Conjugate))
Completed
- Seasonal Allergic Rhinitis
- AIC (Amb a 1 Immunostimulatory Conjugate)
-
Baltimore, MarylandJohns Hopkins University School of Medicine
Dec 12, 2018
Multiple Myeloma Trial (Elotuzumab)
No longer available
- Multiple Myeloma
- Elotuzumab
- (no location specified)
Nov 17, 2021
NSCLC, Stage III Trial in Germany (Durvalumab Injection [Imfinzi], Thoracic Radiotherapy (TRT) conventionally, Thoracic
Recruiting
- NSCLC, Stage III
- Durvalumab Injection [Imfinzi]
- +2 more
-
Aachen, Germany
- +13 more
Nov 29, 2022
COVID-19, COVID-19 Pneumonia, COVID-19 Respiratory Infection Trial in Caracas (Carvacrol, Control group)
Completed
- COVID-19
- +4 more
- Carvacrol
- Control group
-
Caracas, Miranda, VenezuelaHospital Dr. Leopoldo Manrique Terrero - Periférico de Coche.
Jul 5, 2022
Mild Cognitive Impairment, Alzheimer Dementia Trial (CpG1018, Placebo)
Not yet recruiting
- Mild Cognitive Impairment
- Alzheimer Dementia
- CpG1018
- Placebo
- (no location specified)
Jan 3, 2023
Rhinosinusitis Trial in Thái Bình (0.9% NaCl isotonic saline solution, Bacillus subtilis DSM32444, inactivated)
Completed
- Rhinosinusitis
- 0.9% NaCl isotonic saline solution
- Bacillus subtilis DSM32444, inactivated
-
Thái Bình, Thai Binh, VietnamThai Binh University of Medicine and Pharmacy
Aug 8, 2023